.
MergerLinks Header Logo

Announced

Completed

Neuraxpharm completed the acquisition of two product portfolios of Sanofi.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

France

Private

central nervous system-focused products

Acquisition

Friendly

Single Bidder

Cross Border

Medical Equipment

Majority

Completed

Synopsis

Edit

Neuraxpharm, a central nervous system specialist, completed the acquisition of two product portfolios of Sanofi, a pharmaceutical and healthcare company. Financial terms were not disclosed. "These newly acquired products not only strengthen our presence as a leading European specialty pharmaceutical company focused on CNS, but also lay the ground for further expansion of our international presence," Jörg Thomas Dierks, Neuraxpharm CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US